Groupe d'Etude en Oncologie du Quebec

Titre	A Randomized Controlled Trial of Endoscopic Ultrasound Guided Celiac Plexus Neurolysis (EUS-CPN) With and Without Bupivacaine
Protocole ID	21.151
ClinicalTrials.gov ID	NCT04951804
Type(s) de cancer	Pancréas
Phase	Autres
Type étude	Clinique
Médicament	Neurolyse du plexus cœliaque guidé par échographie endoscopique avec ou sans bupivacaine
Institution	CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
Ville	Montréal
Investigateur(trice) principal(e)	Dr Anand Sahai
Coordonnateur(trice)	Charles Mackay 514-890-8000 poste 36484
Statut	Actif en recrutement
Date d'activation	01-08-2022
Critètes d'éligibilité	Malignant-appearing pancreatic mass, or proven pancreatic cancer involving the pancreatic genu, body, or tail Any level of abdominal or back pain considered to be potentially related to the mass: New onset pain (<3 months) Constant Centrally located With or without irradiation to the back No obvious other source of pain based on history and physical examination by the attending endosonographer No possibility of surgical management Signed, informed consent Celiac axis accessible for bilateral neurolysis at EUS.
Critètes d'exclusion	Allergy to bupivacaine

Groupe d'étude en oncologie du Québec